Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cdk5 in Oncology: Recent Advances and Future Prospects
Jimma Likisa Lenjisa, Solomon Tadesse, Nishat Zareen Khair, et al.
Future Medicinal Chemistry (2017) Vol. 9, Iss. 16, pp. 1939-1962
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015–2019)
Concepción Sánchez‐Martínez, Marı́a José Lallena, Sonia Gutiérrez Sanfeliciano, et al.
Bioorganic & Medicinal Chemistry Letters (2019) Vol. 29, Iss. 20, pp. 126637-126637
Closed Access | Times Cited: 178
Overcoming CDK4/6 inhibitor resistance in ER-positive breast cancer
Neil Portman, Sarah Alexandrou, Emma‐Kate Carson, et al.
Endocrine Related Cancer (2018) Vol. 26, Iss. 1, pp. R15-R30
Open Access | Times Cited: 142
Recent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures
Weiyan Cheng, Zhiheng Yang, Suhua Wang, et al.
European Journal of Medicinal Chemistry (2019) Vol. 164, pp. 615-639
Closed Access | Times Cited: 87
Lessons Learned from Past Cyclin-Dependent Kinase Drug Discovery Efforts
Zhouling Xie, Shuzeng Hou, Xiaoxiao Yang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 9, pp. 6356-6389
Closed Access | Times Cited: 46
O-GlcNAc transferase regulates glioblastoma acetate metabolism via regulation of CDK5-dependent ACSS2 phosphorylation
Lorela Ciraku, Zachary A. Bacigalupa, Jing Ju, et al.
Oncogene (2022) Vol. 41, Iss. 14, pp. 2122-2136
Open Access | Times Cited: 42
Physiological and Pathological Roles of Cdk5: Potential Directions for Therapeutic Targeting in Neurodegenerative Disease
Annamarie Allnutt, Ariana Waters, Santosh Kesari, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 9, pp. 1218-1230
Open Access | Times Cited: 64
CDK5: A Unique CDK and Its Multiple Roles in the Nervous System
Nicole Cortés, Leonardo Guzmán‐Martínez, Víctor Andrade, et al.
Journal of Alzheimer s Disease (2019) Vol. 68, Iss. 3, pp. 843-855
Closed Access | Times Cited: 55
CDK5: Key Regulator of Apoptosis and Cell Survival
Rabih Roufayel, Nimer Murshid
Biomedicines (2019) Vol. 7, Iss. 4, pp. 88-88
Open Access | Times Cited: 55
RETRACTED ARTICLE: Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression
Sepideh Izadi, Asma Moslehi, Hadiseh Kheiry, et al.
Pharmaceutical Research (2020) Vol. 37, Iss. 10
Closed Access | Times Cited: 50
Melatonin reduces proliferation and promotes apoptosis of bladder cancer cells by suppressing O‐GlcNAcylation of cyclin‐dependent‐like kinase 5
Jinpeng Wu, Zengqi Tan, Hongjiao Li, et al.
Journal of Pineal Research (2021) Vol. 71, Iss. 3
Closed Access | Times Cited: 40
The Role of CDK5 in Tumours and Tumour Microenvironments
Phuong Anh, Chang Hoon Lee
Cancers (2020) Vol. 13, Iss. 1, pp. 101-101
Open Access | Times Cited: 35
Inhibition of Cdk5 increases osteoblast differentiation and bone mass and improves fracture healing
Mubashir Ahmad, Benjamin Krüger, Torsten Kroll, et al.
Bone Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 18
Machine Learning-Based Virtual Screening for the Identification of Cdk5 Inhibitors
Miriana Di Stefano, Salvatore Galati, Gabriella Ortore, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10653-10653
Open Access | Times Cited: 18
Discovery and Optimization of Highly Selective Inhibitors of CDK5
Matthew H. Daniels, G. Malojcic, Susan L. Clugston, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 4, pp. 3575-3596
Closed Access | Times Cited: 16
Novel Medicinal Chemistry Strategies Targeting CDK5 for Drug Discovery
Wentao Tang, Congcong Lin, Quanwei Yu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 11, pp. 7140-7161
Closed Access | Times Cited: 9
CDK5 Activates Hippo Signaling to Confer Resistance to Radiation Therapy Via Upregulating TAZ in Lung Cancer
Yulan Zeng, Quan Liu, Ye Wang, et al.
International Journal of Radiation Oncology*Biology*Physics (2020) Vol. 108, Iss. 3, pp. 758-769
Open Access | Times Cited: 27
Future Aspects of CDK5 in Prostate Cancer: From Pathogenesis to Therapeutic Implications
Muhammet Oner, Eugene Lin, Mei-Chih Chen, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 16, pp. 3881-3881
Open Access | Times Cited: 26
Discovery of CDK5 Inhibitors through Structure-Guided Approach
Nishat Zareen Khair, Jimma Likisa Lenjisa, Solomon Tadesse, et al.
ACS Medicinal Chemistry Letters (2019) Vol. 10, Iss. 5, pp. 786-791
Open Access | Times Cited: 24
DYRK1A Negatively Regulates CDK5-SOX2 Pathway and Self-Renewal of Glioblastoma Stem Cells
Brianna Chen, Dylan McCuaig-Walton, Sean Jing Xiang Tan, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4011-4011
Open Access | Times Cited: 19
An Orally Bioavailable and Highly Efficacious Inhibitor of CDK9/FLT3 for the Treatment of Acute Myeloid Leukemia
Abel Tesfaye Anshabo, Laychiluh Bantie, Sarah Diab, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1113-1113
Open Access | Times Cited: 10
Divide et Impera: Drp1-mediated Mitochondrial Fission in Glioma Malignancy.
Dianelena Eugenio-Pérez, Alfredo Briones‐Herrera, Elena Martínez‐Klimova, et al.
PubMed (2019) Vol. 92, Iss. 3, pp. 423-433
Closed Access | Times Cited: 17
Identification of Quinazolinone Analogs Targeting CDK5 Kinase Activity and Glioblastoma Cell Proliferation
Marion Peyressatre, Dominique P. Arama, Arthur Laure, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 14
Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma
Liangsong Zhu, Rong Ding, Jianping Zhang, et al.
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 12
Marine-Derived Compounds for CDK5 Inhibition in Cancer: Integrating Multi-Stage Virtual Screening, MM/GBSA Analysis and Molecular Dynamics Investigations
Tagyedeen H. Shoaib, Mohammed A. Almogaddam, Yusra Saleh Andijani, et al.
Metabolites (2023) Vol. 13, Iss. 10, pp. 1090-1090
Open Access | Times Cited: 4
Post-translational modifications of CDK5 and their biological roles in cancer
Gui‐Bin Gao, Yue Sun, Run‐Dong Fang, et al.
Molecular Biomedicine (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top